.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
Merck
Teva
Mallinckrodt
Deloitte
Harvard Business School
Covington
Express Scripts
US Department of Justice
Fuji

Generated: June 24, 2017

DrugPatentWatch Database Preview

Claims for Patent: 8,349,843

« Back to Dashboard

Claims for Patent: 8,349,843

Title:Carboxylic acid derivatives, their preparation and use
Abstract: Carboxylic acid derivatives ##STR00001## where R--R.sup.6, X, Y and Z have the meanings stated in the description, and the preparation thereof, are described. The novel compounds are suitable for controlling diseases.
Inventor(s): Riechers; Hartmut (Neustadt, DE), Klinge; Dagmar (Heidelberg, DE), Amberg; Wilhelm (Friedrichsdorf, DE), Kling; Andreas (Mannheim, DE), Muller; Stefan (Speyer, DE), Baumann; Ernst (Dudenhofen, DE), Rheinheimer; Joachim (Ludwigshafen, DE), Vogelbacher; Uwe (Ludwigshafen, DE), Wernet; Wolfgang (Neustadt, DE), Hager-Wernet, legal representative; Andrea (Neustadt, DE), Unger; Liliane (Ludwigshafen, DE), Raschack; Manfred (Weisenheim, DE)
Assignee: Abbott GmbH & Co. KG (Wiesbaden, DE)
Application Number:13/267,178
Patent Claims: 1. A pharmaceutical composition comprising a compound of formula I: ##STR00016## or a pharmaceutically acceptable salt thereof, where R is a COOH group or a radical which can be hydrolyzed to COOH; R.sup.2 is a C.sub.1-C.sub.4-alkyl or C.sub.1-C.sub.4-alkoxy; X is CR.sup.14 where R.sup.14 is hydrogen or C.sub.1-C.sub.5-alkyl, or CR.sup.14 forms together with CR.sup.3 a 5- or 6-membered alkylene or alkenylene ring which can be substituted by one or two C.sub.1-C.sub.4-alkyl groups and in which in each case a methylene group can be replaced by an oxygen; R.sup.3 is a C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-alkoxy or CR.sub.3 is linked to CR.sub.14 as indicated above to give a 5- or 6-membered ring; R.sup.4 and R.sup.5 are each independently phenyl or naphthyl, a methylene, ethylene or ethenylene group, an oxygen or sulfur atom or an SO.sub.2, NH or N-alkyl group or a C.sub.3-C.sub.7-cycloalkyl; R.sup.6 is a hydrogen, C.sub.1-C.sub.8 alkyl, or C.sub.3-C.sub.8-cycloalkyl, where each of these radicals can be substituted with one or more substituents selected from the group consisting of: halogen, nitro, cyano, C.sub.1-C.sub.4-alkoxy, C.sub.3-C.sub.6-alkenyloxy, C.sub.3-C.sub.6-alkynyloxy, C.sub.1-C.sub.4-alkylthio, C.sub.1-C.sub.4-haloalkoxy, C.sub.1-C.sub.4-alkylcarbonyl, C.sub.1-C.sub.4-alkoxycarbonyl, C.sub.1-C.sub.8-alkylcarbonylalkyl, C.sub.1-C.sub.4-alkylamino, di-C.sub.1-C.sub.4-alkylamino, unsubstituted phenyl, and phenyl or phenoxy, wherein phenyl or phenoxy is substituted by one or more substituents selected from the group consisting of: halogen, nitro, cyano, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-haloalkyl, C.sub.1-C.sub.4-alkoxy, C.sub.1-C.sub.4-haloalkoxy and C.sub.1-C.sub.4-alkylthio; or R.sup.6 is phenyl or naphthyl, each of which can be substituted by one or more radicals selected from the group consisting of: halogen, nitro, cyano, hydroxyl, amino, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-haloalkyl, C.sub.1-C.sub.4-alkoxy, C.sub.1-C.sub.4-haloalkoxy, phenoxy, C.sub.1-C.sub.4-alkylthio, C.sub.1-C.sub.4-alkylamino, C.sub.1-C.sub.4-dialkylamino, dioxomethylene and dioxoethylene; Y is oxygen; and Z is oxygen; and a pharmaceutically acceptable carrier.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Deloitte
US Department of Justice
Farmers Insurance
Moodys
Boehringer Ingelheim
McKinsey
Cerilliant
Baxter
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot